Graphical Abstract Plain Language Summary Semaglutide is a medicine that can help people lose weight and improve other health conditions
Individual variations in carnitine status, mitochondrial density, and metabolic flexibility all influence outcomes
Bliddal H, Bays H, Czernichow S, et al
Although an increase in heart-rate per se is not a major problem for most people, it is salient in the case of GLP1R, GIPR or GR agonists since the target patient population of these agonist are obese patients, who likely already suffer from cardiovascular complications
Flow Wellness will help you make sense of it
However, even if we had identified some expression, it would not alter our interpretation that there are no molecular markers indicative of whether a cell forms synapses